Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Proteomics International Laboratories Ltd. ( (AU:PIQ) ).
Proteomics International Laboratories Ltd announced the issuance of 5,405,399 unquoted securities, set to expire on May 31, 2026, with an exercise price of $0.50. This issuance is part of previously announced transactions and is not intended to be quoted on the ASX. The move may impact the company’s financial structure and provide additional capital for its ongoing projects.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd operates in the biotechnology industry, focusing on the development and commercialization of diagnostic tests and analytical services. The company is known for its innovative approaches in proteomics, which is the large-scale study of proteins, particularly their structures and functions.
YTD Price Performance: -51.25%
Average Trading Volume: 132,410
Technical Sentiment Signal: Buy
Current Market Cap: A$51.09M
For detailed information about PIQ stock, go to TipRanks’ Stock Analysis page.